Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PHIO on Nasdaq
Shares outstanding
10,994,020
Price per share
$1.02
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
188,486
Total reported value
$467,442
% of total 13F portfolios
0%
Share change
+23,351
Value change
+$59,963
Number of holders
11
Price from insider filings
$1.02
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 9.9% +100% $1,730,692 +$1,515,960 733,344 +706% CVI Investments, Inc. 03 Nov 2025
Orca Capital AG 4.9% -23% $662,610 -$198,908 538,707 -23% Orca Capital AG 08 Dec 2025
INTRACOASTAL CAPITAL, LLC 7% -30% $1,014,800 -$236,404 430,000 -19% Mitchell P. Kopin 30 Sep 2025

As of 30 Sep 2025, 11 institutional investors reported holding 188,486 shares of Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO). This represents 1.7% of the company’s total 10,994,020 outstanding shares.

Institutional Holders of Phio Pharmaceuticals Corp. - Common Stock, par value $0.0001 per share (PHIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 188,486 $467,442 +$59,963 $2.48 11
2025 Q2 164,722 $387,355 +$164,979 $2.35 11
2025 Q1 100,618 $130,801 -$133,234 $1.30 10
2024 Q4 153,843 $277,072 +$183,356 $1.80 10
2024 Q3 28,506 $98,345 +$98,345 $3.45 6